维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="M borad"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Gemcitabine plus nab-paelitaxel is an active regimen in patients with advancedpancreatic cancer: a phase I /~ trial显示文摘	Yon Hoff DD Ramanathan RK Borad M J	2011	J Clin Oncol2011，29，34：	1
	2	Isolation of ac DNA clone and localization of the human glutathione S transferase 3 genes to chromosome bands 11q13 and 12q13 14显示文摘	Borad P G Webb G C Coggan M	1989	Ann Hum Genet1989，33，3：	1
	3	Efficacy ofmelphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refraetory multiple myeloma显示文摘	Borad M J Swift R Berenson JR	2005	Leukemia2005，19，1：	1
	4	Gemcitabine plusnab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase Ⅰ/Ⅱ Trial 显示文摘	Von Hoff DD Ramanathan RK Borad M J	2011	J Clin Oncol2011，29，34：	1
	5	SPARC correlation with response to gemcimbine plus nab-paclitaxel in patients with advanced metastatic pancreatic cancer:A phase Ⅰ/Ⅱ study显示文摘	Von Hoff DD Ramanathan R Borad M	2009	J Clin Oncol2009，27，：	1
	6	SPARC correlation with response to gemcitabine (G) plus nab- paclitaxel ( nab -P) in patients with advanced pancreatic cancer: a phase 1/2 study显示文摘	D von Hoff R Ramanathan M borad	2009	ASCO2009，3，：	1
	7	SPARC correla- tion with response to gemcitabin(G) plus nab-paclitaxel(nab-P) in patient with advanced pancreatic cancer: a phase 1/2 study 显示文摘	von Hoff DD Ramanatham R Borad M	2009	J Clin Oncol2009，27，15：	1
	8	Melphalan, arsenic trioxide (ATO), and ascorbic acid combination therapy(MAC) for treatment of refractory multiple myeloma(MM) 显示文摘	Borad M J Vescio RA Yang HH	2003	Proc Am Soc Clin Oncol2003，22，2427：	1
	9	Gem- citabine plus nab-paclitaxel is an active regimen in patients with ad- vanced pancreatic cancer : a phase I / II trial显示文摘	VON HOFF D D RAMANATHAN R K BORAD M J	2011	J Clin Oncol2011，29，34：	1
	10	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer : a phase I / II trial 显示文摘	Von Hoff DD Ramanalhan RK Borad M J	2011	J Clin Oncol2011，29，34：	1
	11	SPARC correlation with response to gemcitabine (G) plus nab-paclitaxel (nab-P) in pa-tients with advanced metastatic pancreatic cancer:A phase I/II study显示文摘	Von Hoff DD Ramanathan R Borad M	2009	J Clin Oncol2009，27，15：	1
	12	Ranomized phase II trial of gemcitabine plus TH-302 versus gemcit- abine in patients with advanced pancreatic cancer 显示文摘	Borad M J Reddy S G Bahary N	2015	Journal of Clinical Oncology2015，33，13：	1
	13	Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer 显示文摘	Borad M J Reddy SG Bahary N	2013	J Clin Oncol2013，33，13：	1
	14	Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pan- creatic cancer: a phaseⅠ/Ⅱ trial 显示文摘	Von Hoff DD Ramanathan RK Borad M J	2011	J Clin Oncol2011，29，34：	1
	15	Cholangiocarcinoma: molecular pathways and therapeutic opportunities 显示文摘	Rizvi S Borad M J Patel T	2014	Semin Liver Dis2014，34，4：	1
	16	SPARC correlation with response to gemcitabine (G) plus nab-paclitaxel (nab- P) in patients with advanced metastatic pancreatic cancer: A phase Ⅰ/Ⅱ study 显示文摘	Von Hoff DD Ramanathan R Borad M	2009	J Clin Oncol2009，27，15：	1
	17	Surface defects incorporated diamond machining of silicon显示文摘This paper reports the performance enhancement benefits in diamond turning of the silicon wafer by incorporation of the surface defect machining(SDM)method.The hybrid micromachining methods usually require additional hardware to leverage the added advantage of hybrid technologies such as laser heating,cryogenic cooling,electric pulse or ultrasonic elliptical vibration.The SDM method tested in this paper does not require any such additional baggage and is easy to implement in a sequential micro-machining mode.This paper made use of Raman spectroscopy data,average surface roughness data and imaging data of the cutting chips of silicon for drawing a comparison between conventional single-point diamond turning(SPDT)and SDM while incorporating surface defects in the(i)circumferential and(ii)radial directions.Complementary 3D finite element analysis(FEA)was performed to analyse the cutting forces and the evolution of residual stress on the machined wafer.It was found that the surface defects generated in the circumferential direction with an interspacing of 1 mm revealed the lowest average surface roughness(Ra)of 3.2 nm as opposed to 8 nm Ra obtained through conventional SPDT using the same cutting parameters.The observation of the Raman spectroscopy performed on the cutting chips showed remnants of phase transformation during the micromachining process in all cases.FEA was used to extract quantifiable information about the residual stress as well as the sub-surface integrity and it was discovered that the grooves made in the circumferential direction gave the best machining performance.The information being reported here is expected to provide an avalanche of opportunities in the SPDT area for low-cost machining solution for a range of other nominal hard,brittle materials such as SiC,ZnSe and GaAs as well as hard steels.	Neha Khatri Borad M Barkachary B Muneeswaran Rajab Al-Sayegh Xichun Luo Saurav Goel	2020	International Journal of Extreme Manufacturing2020，2，4：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费